EMEA-000071-PIP01-07
Key facts
| Invented name |
PegIntron
|
| Active substance |
peginterferon alfa-2b
|
| Therapeutic area |
Gastroentology-Hepatology
|
| Decision number |
P/64/2008
|
| PIP number |
EMEA-000071-PIP01-07
|
| Pharmaceutical form(s) |
Powder and solvent for solution for injection in vial and in pre-filled pen
|
| Condition(s) / indication(s) |
Treatment of chronic viral hepatitis C
|
| Route(s) of administration |
Subcutaneous use
|
| Contact for public enquiries |
Merck Sharp & Dohme (Europe), Inc.
|
| Decision type |
P: decision agreeing on a investigation plan, with or without partial waiver(s) and or deferral(s)
|
| Compliance procedure number |
EMEA-C-000071-PIP01-07
|
| Compliance opinion date |
17/10/2008
|
| Compliance outcome |
positive
|